Fierce Biotech August 9, 2024
Heather Landi

Zimmer Biomet plans to acquire AI surgical guidance company OrthoGrid Systems to expand its market share in hip replacement procedures.

The acquisition includes OrthoGrid’s AI-powered, fluoroscopy-based surgical assistance platform Hip AI as well as two additional FDA-cleared orthopedic applications and more than 40 patents, the company announced this week.

The transaction is expected to be completed by the end of the fourth quarter of 2024. Financial details were not disclosed.

The orthopedics-focused medical technology company said the proposed acquisition will expand its hip portfolio with AI-driven surgical guidance system.

“OrthoGrid’s AI systems address the rapidly growing market demand for fluoroscopy-based surgical guidance solutions while strengthening our portfolio of hip offerings that drive intraoperative efficiencies and improve the quality of life...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Medical Devices, Mergers & Acquisitions / JV, Technology, Trends
OCT Medical Devices 2025: AI’s value appreciable, yet human touch remains key
GE HealthCare invests $138M in new contrast media manufacturing site amid rising demand
Medical Device Makers Seek Exemption From Trump Tariffs
STAT+: How Trump’s tariffs may raise health care costs, from medical devices to prescription drugs
Medical device cyber updates must consider patient safety

Share This Article